Effect of supplementation in treatment of women with polycystic ovary syndrome

Phase 3

• Conditions: Polycystic ovary syndrome.; Polycystic ovarian syndrome; E28.2

• Registration Number: IRCT201605225623N80
• Lead Sponsor: Vice chancellor for research, Arak University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 September 2020

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 60

Inclusion Criteria

Patients with PCOS according to Rotterdam criteria
Aged 18 to 40 years

Exclusion Criteria

Pregnant women
Adrenal hyperplasia
Androgen-secreting tumors
Hyperprolactinaemia
Thyroid dysfunction
Diabetes or impaired glucose tolerance
Gastrointestinal problems
No hormonal treatments in the previous 6 months in the study

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Expressed levels of PPAR-?. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: PCR.;Expressed levels of GLUT1 gene. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: PCR.;Serum insulin. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Eliza.;Insulin resistance. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Calculation with HOMA formula.